Hodgkin lymphoma (HL) has unique epidemiologic characteristics. The variation in
incidence according to age, sex, race, socioeconomic status, and histologic subtype …

Despite its well‐known histological and clinical features, Hodgkin′ s lymphoma (HL) has
recently been the object of intense research activity, leading to a better understanding of its …

In the past decade there have been many advances in our understanding of Hodgkin's
disease. Among the most important is the discovery that the Reed–Sternberg cell is a …

Abstract The Hodgkin and Reed-Sternberg (HRS) tumor cells of classical Hodgkin
lymphoma (HL), as well as the lymphocyte predominant (LP) cells of nodular lymphocyte …

Hodgkin lymphoma (HL) is a lymphatic malignancy with an estimated annual incidence of
80,000 cases world-wide. Modern therapy promises 5-year survival rates exceeding 90% for …

According to the WHO classification, Hodgkin's lymphoma (HL) is subdivided into a classical
variant and a nodular lymphocyte predominant variant which are characterized by the …

Hodgkin lymphoma (HL) is a distinctive lymphoma subtype that accounts for approximately
30% of all lymphomas in the Western world and approximately 5% in Japan. HL is …

Hodgkin's lymphoma (HL) has a unique and distinct history, epidemiology, treatment, and
biology. A viral agent or infectious agent has long been considered as the etiologic agent …

Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however,
remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the …

Despite its well known histological and clinical features, Hodgkin's lymphoma (HL) has
recently been the object of intense research activity, leading to a better understanding of its …